Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A critical component of T2DM is a chronic low-grade inflammatory state, referred to as “metaflammation” [250].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Among them, the UKPDS post-trial study and Steno-2 trial showed that specifically early glycemic interventions prevent diabetic complication and has a marked decrease in CVD endpoints in patients that received either standard or intensive treatment following their diagnosis [84].”
BackgroundHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“In these circumstances, as a consequence of nutrient overload, electron supply to the mitochondrial ETC increases and the electron excess is transferred to oxygen generating O2− and subsequent hydrogen peroxide [127].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“A high-fat diet can induce up to threefold lipopolysaccharide (from Gram-negative bacteria) production in mice models, thereby contributing to low-grade inflammation and insulin resistance [76,77].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Research works printed but not linked: 1
- Simmons D. Epigenetic Influences and Disease Nat. Educ. 2008 1 6
Cited by
Items 201–300 of 1,005
Li, J., Nie, Z., Ge, Z., Shi, L., Gao, B., & Yang, Y. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01691-1 · Cited by 44
“Introduction Type 2 diabetes mellitus (T2DM) is an abnormality in glucose metabolism and related metabolic disorders caused by inadequate insulin secretion or ineffective cellular response to insulin [1, 2].”
BackgroundTherapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside
Xie, F., Song, Y., Yang, Y., Jiang, X., Ma, S., Ma, C., Li, J., Zhanghuang, Z., Liu, M., Zhao, P., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16040541 · Cited by 41
“ing in a relative lack of insulin [8].”
BackgroundRanbhise, J. S., Ju, S., Singh, M. K., Han, S., Akter, S., Ha, J., Choe, W., Kim, S. S., & Kang, I. (2025) · Dentistry Journal · doi:10.3390/dj13030100 · Cited by 54
“The pathophysiology involves a complex interaction between genetic susceptibility and environmental triggers [78].”
Taylor, H. J., Hung, Y.-H., Narisu, N., Erdos, M. R., Kanke, M., Yan, T., Grenko, C. M., Swift, A. J., Bonnycastle, L. L., Sethupathy, P., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206797120 · Cited by 36
Endothelial Insulin Resistance Exacerbates Experimental Periodontitis
Zeze, T., Shinjo, T., Sato, K., Nishimura, Y., Imagawa, M., Chen, S., Ahmed, A.-K., Iwashita, M., Yamashita, A., Fukuda, T., et al. (2023) · Journal of Dental Research · doi:10.1177/00220345231181539 · Cited by 39
“Type 2 diabetes mellitus is mainly caused by 2 primary factors: defective insulin secretion by pancreatic β-cells and the attenuation of response to insulin (Galicia-Garcia et al. 2020).”
BackgroundCopper and Diabetes: Current Research and Prospect
Chang, W., & Li, P. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300468 · Cited by 46
Chen, M., Li, D., Meng, X., Sun, Y., Liu, R., & Sun, T. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128565 · Cited by 42
Diabetes Mellitus and Infectious Diseases: Current Evidence and Clinical Implications
Kim, T., & Choi, S. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0508 · Cited by 62
Muller, C. J. F., Joubert, E., Chellan, N., Miura, Y., & Yagasaki, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010356 · Cited by 41
“The main causal factors that fuel T2D development include insulin resistance (IR), inflammation and oxidative stress [82].”
BackgroundType 2 Diabetes and the Microbiome
Barlow, G. M., & Mathur, R. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac184 · Cited by 49
Mitochondrial Dysfunction as a Factor of Energy Metabolism Disorders in Type 2 Diabetes Mellitus
Blagov, A. V., Nedosugova, L., Kirichenko, T. V., Sukhorukov, V. N., Melnichenko, A. А., & Orekhov, A. N. (2024) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1601005 · Cited by 45
“…immunoreactive insulin and glucagon may be normal in T2DM patients, testing the islet function at appropriate glucose levels reveals various abnormalities in insulin and glucagon secretion due to decreased β -cell secretory capacity and impaired ability of glucose to suppress glucagon release [22].”
Ranade, S. D., Alegaon, S. G., Khatib, N. A., Gharge, S., Kavalapure, R. S., & Kumar, B. R. P. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138359 · Cited by 37
Wang, P., Fan, Y., Gao, H., & Wang, B. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111958 · Cited by 41
Associated factors and principal pathophysiological mechanisms of type 2 diabetes mellitus
Wang, L., Li, L., Liu, J., Sheng, C., Yang, M., Hu, Z., & Yue, R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1499565 · Cited by 65
Ballan, R., & Saad, S. M. I. (2021) · Foods · doi:10.3390/foods10112528 · Cited by 40
“Patients with T2DM usually have a high-fat diet that is associated with increased lipopolysaccharide production by Gram-negative bacteria in the gut, and its passage to the blood circulation triggers inflammatory responses that lead to insulin resistance [6].”
BackgroundYan, M., Man, S., Ma, L., & Gao, W. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155264 · Cited by 35
Therapeutic Role of Curcumin in Diabetes: An Analysis Based on Bioinformatic Findings
Mahmoudi, A. A., Atkin, S. L., Nikiforov, N. G., & Sahebkar, A. (2022) · Nutrients · doi:10.3390/nu14153244 · Cited by 35
“Inadequate insulin production and/or decreased tissue responses cause insulin deficiency along the complicated hormone activity pathways at one or more locations [2,3].”
BackgroundRecent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease
Andreadi, A., Muscoli, S., Tajmir, R., Meloni, M., Muscoli, C., Ilari, S., Mollace, V., Della‐Morte, D., Bellia, A., Daniele, N. D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021646 · Cited by 39
“IR is considered the “primum movens” of T2D and is associated with poor insulin action, decreased cell signaling, and decreased insulin sensitivity in peripheral target tissues (liver, muscle, and adipose tissue) where metabolic/nutrient utilization and storage decreases and catabolic processes increase [11].”
BackgroundAdvances in buccal and oral delivery of insulin
Elsayed, A., Al-Remawi, M. M., Jaber, N., & Abu–Salah, K. M. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122623 · Cited by 37
Serbis, A., Giapros, V. I., Tsamis, K. I., Balomenou, F., Galli‐Τsinopoulou, A., & Siomou, E. C. (2023) · Nutrients · doi:10.3390/nu15092217 · Cited by 46
“Type 2 diabetes mellitus (T2D) is a heterogeneous disorder characterized by hyperglycemia caused by the combination of an increasing insulin resistance together with a gradual β-cell failure [1].”
BackgroundPaquette, S., Thomas, S. C., Venkataraman, K., Appanna, V. D., & Tharmalingam, S. (2023) · Nutrients · doi:10.3390/nu15214690 · Cited by 40
“Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder in which the body cannot secrete enough insulin or does not respond appropriately to insulin [1].”
BackgroundJazieh, C., Arabi, T. Z., Asim, Z., Sabbah, B. N., Alsaud, A. W., Alkattan, K., & Yaqinuddin, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1295967 · Cited by 40
“The cornerstones of T2DM pathogenesis are IR and b -cell dysfunction, resulting in reduced insulin secretion (34).”
BackgroundAlfatama, M., Choukaife, H., Alkhatib, H., Rahal, O. A., & Zin, N. Z. M. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2023-0205 · Cited by 44
“Ultimately, the metabolism of lipids, proteins, and carbohydrates is signi fi cantly regulated by insulin [21].”
BackgroundKurniawan, L. B. (2024) · PubMed Central · Cited by 92
Rolver, M. G., Emanuelsson, F., Nordestgaard, B. G., & Benn, M. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02207-0 · Cited by 42
Ranade, S. D., Alegaon, S. G., Khatib, N. A., Gharge, S., & Kavalapure, R. S. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00344f · Cited by 35
Photosynthesis: Genetic Strategies Adopted to Gain Higher Efficiency
Khan, N., Choi, S., Lee, C.-H., Qu, M., & Jeon, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168933 · Cited by 39
“PRK is vital for RuBP regeneration; increased PRK expression boosts RuBP production but causes metabolic imbalances if not regulated [87].”
BackgroundBenák, D., Sevcikova, A., Holzerová, K., & Hlaváčková, M. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1500394 · Cited by 47
Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
Ji, L., Ma, J., Ma, Y., Cheng, Z., Gan, S., Yuan, G., Liu, D., Li, S., Liu, Y., Xue, X., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.62185 · Cited by 45
Noninvasive On-Skin Biosensors for Monitoring Diabetes Mellitus
Sedighi, A., Kou, T., Huang, H., & Li, Y. (2025) · Nano-Micro Letters · doi:10.1007/s40820-025-01843-9 · Cited by 52
Duan, K., Yan, X., Gao, Z., Hou, Y., Lv, X., & Song, G. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13775 · Cited by 41
Bays, H. E., Golden, A., & Tondt, J. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100034 · Cited by 34
No Time to Die—How Islets Meet Their Demise in Transplantation
Kale, A., & Rogers, N. M. (2023) · Cells · doi:10.3390/cells12050796 · Cited by 42
“Type 2 DM (T2DM) is caused by a combination of β-cell dysfunction and insulin resistance [2].”
BackgroundCarrizales-Sánchez, A. K., Tamez‐Rivera, O., Rodríguez-Gutiérrez, N. A., Elizondo‐Montemayor, L., Hernandez, M. S. G., García‐Rivas, G., Pacheco, A., & Senés‐Guerrero, C. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-03983-6 · Cited by 37
“Insulin resistance (IR) is one of the risk factors that characterize MetS, which is promoted by an abnormal accumulation of adipose tissue through the activation of various inflammatory mechanisms, such as adipokine deregulation and an increase in free fatty acid release, affecting the functionality of relevant organs…”
BackgroundNew insights into anti-diabetes effects and molecular mechanisms of dietary saponins
Zhou, Y., & Xu, B. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2101425 · Cited by 41
“K + -ATPase, glucose transporter (GLUT)-2, and disaccharidases, are essential for carbohydrates digestion and monosaccharides absorption (Galicia-Garcia et al. 2020; Han, Hui, and Wang 2008).”
BackgroundChen, D., Chen, X., He, C., xiao, C., Chen, Z., Chen, Q., Chen, J., & Bo, H. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116162 · Cited by 33
Research Progress on the Construction and Application of a Diabetic Zebrafish Model
Cao, Y., Chen, Q., Liu, Y., Jin, L., & Peng, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065195 · Cited by 40
Inhibition of GSK3B phosphorylation improves glucose and lipid metabolism disorder
Yan, Z., Cao, X., Sun, S., Sun, B., & Gao, J. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166726 · Cited by 38
A Comprehensive Overview of Skin Complications in Diabetes and Their Prevention
David, P., Singh, S., & Ankar, R. S. (2023) · Cureus · doi:10.7759/cureus.38961 · Cited by 71
“While the diagnosis of diabetes is concerning in and of itself, it is further complicated by a range of potential complications that can significantly impact the health outcomes of those with the disease [8].”
BackgroundWalking speed and the risk of type 2 diabetes: a systematic review and meta-analysis
Jayedi, A., Zargar, M. S., Emadi, A., & Aune, D. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2023-107336 · Cited by 48
Asiri, A., Qarni, A. A. A., & Bakillah, A. (2024) · Diagnostics · doi:10.3390/diagnostics14192132 · Cited by 44
“T2DM is the inability of the body’s cells to absorb and use insulin, leading to the accumulation of glucose in the blood, which is defined as insulin resistance [41,42].”
BackgroundTokalı, F. S., Demir, Y., Ateşoğlu, Ş., Tokalı, P., & Şenol, H. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70033 · Cited by 41
Suttithumsatid, W., Shah, M. A., Bibi, S., & Panichayupakaranant, P. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.07.002 · Cited by 44
“Extended period of uncontrolled hyperglycemia usually cause severe damage to many organs and tissue including nerves, and blood vessels (Galicia-Garcia et al., 2020).”
BackgroundNatur, S., Damri, O., & Agam, G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19159398 · Cited by 39
“Type 2 diabetes (T2D) (formerly adult-onset diabetes), a typically chronic illness, is characterized by high blood sugar, insulin resistance, and relative lack of insulin [7].”
BackgroundJiang, Y., Feng, C., Shi, Y., Kou, X., & Le, G. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1039753 · Cited by 33
“Type 2 diabetes mellitus is caused by a variety of factors, one of which is a high-fat diet that leads to decreased insulin sensitivity and, consequently, insulin resistance (29).”
BackgroundChávez-Delgado, E. L., & Jacobo‐Velázquez, D. A. (2023) · Foods · doi:10.3390/foods12051079 · Cited by 39
“Two primary factors are involved in the development of type 2 diabetes (T2D): impaired insulin secretion by pancreatic β-cells or a lowered number of β-cell mass, which may also contribute to insufficient secretion of insulin and the inability of insulin-sensitive tissues to respond appropriately to this hormone [35].”
BackgroundCXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
Chen, C., Lin, L., Chen, J., & Chang, T. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01900-w · Cited by 33
Mancinetti, F., Xenos, D., Fano, M. D., Mazzieri, A., Porcellati, F., Boccardi, V., & Mecocci, P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102018 · Cited by 37
Zeinhom, A., Fadallah, S. A., & Mahmoud, M. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03974-z · Cited by 46
“Patients with T2D are not sensitive to insulin and produce insufficient amounts of the hormone in the advanced disease stages [4, 5].”
BackgroundTaderegew, M. M., Woldeamanuel, G. G., Wondie, A., Getawey, A., Abegaz, A. N., & Adane, F. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075607 · Cited by 54
Ketone Bodies in Diabetes Mellitus: Friend or Foe?
Veneti, S., Grammatikopoulou, M. G., Kintiraki, E., Mintziori, G., & Goulis, D. G. (2023) · Nutrients · doi:10.3390/nu15204383 · Cited by 40
“Type 2 DM (T2DM) is hallmarked by a progressive loss of adequate insulin secretion from the β -cells as the result of insulin resistance (IR) [6].”
BackgroundYachmaneni, A., Jajoo, S. N., Mahakalkar, C. C., Kshirsagar, S., & Dhole, S. (2023) · Cureus · doi:10.7759/cureus.47525 · Cited by 70
NADPH Dynamics: Linking Insulin Resistance and β-Cells Ferroptosis in Diabetes Mellitus
Moon, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010342 · Cited by 38
“This insulin resistance can eventually strain the pancreatic β -cells, reducing their ability to produce insulin [70,71].”
Shahzad, N., Alzahrani, A. R., Ibrahim, I. A. A., Shahid, I., Alanazi, I. M., Falemban, A. H., Imam, M. T., Mohsin, N., Azlina, M. F. N., & Arulselvan, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24207 · Cited by 38
“Various genetic and environmental variables influence its etiology and development [16 – 18].”
BackgroundRetractedInterplay of mitochondria and diabetes: Unveiling novel therapeutic strategies
Liang, K. X. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101850 · Cited by 38
Garza, M. C., Pérez‐Calahorra, S., Rodrigo‐Carbó, C., Sánchez-Calavera, M. A., Jarauta, E., Mateo‐Gállego, R., Gracia‐Rubio, I., & Lamíquiz-Moneo, I. (2024) · Nutrients · doi:10.3390/nu16060756 · Cited by 43
Gerontiti, E., Shalit, A., Stefanaki, K., Kazakou, P., Karagiannakis, D. S., Peppa, Μ., Ψαλτοπούλου, Θ., & Paschou, S. Α. (2024) · HORMONES · doi:10.1007/s42000-024-00566-7 · Cited by 57
Chauhan, A., Dubey, S., & Jain, S. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4111 · Cited by 37
Ahmad, S., Ahmad, M. F. A., Khan, S., Alouffi, S., Khan, M., Prakash, C., Khan, M. W. A., & Ansari, I. A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135761 · Cited by 40
Mir, R., Jeelani, M., Alharthi, M. H., Rizvi, S. F., Sohail, S. K., Wani, J. I., Sabah, Z. U., BinAfif, W. F., Nandi, P. S., Alshahrani, A. M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062770 · Cited by 53
“Insulin resistance thus fosters obesity, T2DM, and its complications, including non-alcoholic fatty liver disease (NAFLD), tumors, cardiovascular disease, and other metabolic disorders [134,135].”
Sangouni, A. A., Abdollahi, S., & Mozaffari–Khosravi, H. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02637-2 · Cited by 35
Wu, X., Yang, J., Mumby, W., Zhang, Y., Zhang, Y., Wang, C., Chen, X., Suo, H., & Song, J. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.104129 · Cited by 31
Managing Diabetes Mellitus With Millets: A New Solution
Agrawal, P., Singh, B. R., Gajbe, U., Kalambe, M. A., & Bankar, M. (2023) · Cureus · doi:10.7759/cureus.44908 · Cited by 45
“Exhaustion of glucose transporters in the intestine and kidney is also a line of cause for DM [3,4].”
BackgroundYang, C., Lan, R., Lijun, Z., Pu, J., Hu, D., Yang, J., Zhou, H., Han, L., Ye, L., Jin, D., et al. (2024) · mSystems · doi:10.1128/msystems.00532-24 · Cited by 43
“T2DM is primarily caused by defective insulin secretion by pancreatic β -cells and reduced sensitivity of the body to insulin (8).”
Hosseini, H., Bagherniya, M., Sahebkar, A., Iraj, B., Majeed, M. A., & Askari, G. (2024) · Phytotherapy Research · doi:10.1002/ptr.8304 · Cited by 34
Role of FoxO1 in regulating autophagy in type 2 diabetes mellitus (Review)
Li, X., Wan, T., & Li, Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10139 · Cited by 39
Cifuentes‐Mendiola, S. E., Solís-Suárez, D. L., Martínez-Dávalos, A., Godínez‐Victoria, M., & García‐Hernández, A. L. (2021) · Bone · doi:10.1016/j.bone.2021.116292 · Cited by 33
Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview
Palihaderu, P. A. D. S., Mendis, B. S. S., Premarathne, J. M. K. J. K., Dias, W., Yeap, S. K., Ho, W. Y., Dissanayake, A., Rajapakse, I. H., Karunanayake, P., Senarath, U., et al. (2022) · Epigenetics Insights · doi:10.1177/25168657221130041 · Cited by 37
Famuyiwa, S. O., Ahmad, S., Fakola, E. G., Olusola, A. J., Adesida, S. A., Obagunle, F. O., Raza, K., Ugwo, J. P., Oyelekan, E. I., & Faloye, K. O. (2023) · Chemistry Africa · doi:10.1007/s42250-023-00604-8 · Cited by 31
“The disease is known to occur due to abnormalities in glucose metabolic pathways, primarily due to the inactivity or excessive action of diabetic enzymes [3].”
BackgroundThe Role of Heme and Copper in Alzheimer’s Disease and Type 2 Diabetes Mellitus
Pal, I., & Dey, S. G. (2023) · JACS Au · doi:10.1021/jacsau.2c00572 · Cited by 32
Diabetes mellitus type 2 as an underlying, comorbid or consequent state of mental disorders
Borovčanin, M., Vesić, K., Petrović, I., Jovanović, I., & Mijailović, N. R. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.481 · Cited by 38
Ranade, S. D., Alegaon, S. G., Khatib, N. A., Gharge, S., Kavalapure, R. S., & Kumar, B. R. P. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116939 · Cited by 31
Uti, D. E., Atangwho, I. J., Alum, E. U., Egba, S. I., Ugwu, O. P.-C., & Ikechukwu, G. C. (2025) · Natural Product Communications · doi:10.1177/1934578x251323393 · Cited by 74
Risk factors for mild cognitive impairment in type 2 diabetes: a systematic review and meta-analysis
Zhao, Y., Wang, H., Tang, G., Wang, L., Tian, X., & Li, R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1617248 · Cited by 46
The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus
Benák, D., Benáková, Š., Plecitá‐Hlavatá, L., & Hlaváčková, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1223583 · Cited by 35
“This heterogeneous systemic disorder is mainly characterized by two factors: deficient insulin secretion by pancreatic b-cells and insulin resistance of insulin-sensitive tissues (3).”
BackgroundTreatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling
He, H., Wang, H., Chen, X., Zhong, Y., Huang, X. R., Ronald, C. W., Wang, C., & Lan, H.-Y. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.87820 · Cited by 41
Ghazaly, M. M., Lee, G. E., Ling, N., Hědenec, P., Maulidiani, M., Hassan, N. R., Zulkifli, M. F., Mohammed, A., & Ghazali, M. S. M. (2024) · Food & medicine homology. · doi:10.26599/fmh.2025.9420068 · Cited by 42
Jayaraman, S., Prasad, M., Natarajan, S. R., Krishnamoorthy, R., Alshuniaber, M. A., Gatasheh, M. K., Veeraraghavan, V. P., Rajagopal, P., & Palanisamy, C. P. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111443 · Cited by 29
Genetics of diabetes and its complications: a comprehensive review
Sami, A., Javed, A., Ozsahin, D. U., Özşahin, İ., Muhammad, K., & Waheed, Y. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01748-y · Cited by 56
Wang, D., Zhang, X., Li, Y., Jia, L., Zhai, L., Wei, W., Zhang, L., Jiang, H., & Bai, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.940673 · Cited by 33
“insulin signaling pathway and, as a result, a reduction in GLUT-4 levels (70).”
BackgroundSharma, A., Dubey, R., Bhupal, R., Patel, P., Verma, S. K., Kaya, S., & Asati, V. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10728-1 · Cited by 42
“The organs involved in T2DM development include the pancreas (β-cells and α-cells) [12], liver, skeletal muscle, kidneys, brain, small intestine, and adipose tissue.”
Vaccinium uliginosum and Vaccinium myrtillus—Two Species—One Used as a Functional Food
Kopystecka, A., Kozioł, I., Radomska, D., Bielawski, K., Bielawska, A., & Wujec, M. (2023) · Nutrients · doi:10.3390/nu15194119 · Cited by 29
A review of photobiomodulation on PI3K/AKT/mTOR in wound healing
Kasowanjete, P., Kumar, S. S. D., & Houreld, N. N. (2023) · Journal of Photochemistry and Photobiology · doi:10.1016/j.jpap.2023.100215 · Cited by 35
Fan, S., Liu, Q., Du, Q., Zeng, X., Wu, Z., Pan, D., & Tu, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134993 · Cited by 38
Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review of Structure-Activity Relationship Studies
Bayanati, M., Rabbani, M. I. M., Kabiri, S. S., Sadegh, B. M. M., Rezaee, E., & Tabatabai, S. A. (2024) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-151581 · Cited by 36
“In T 1 DM, an autoimmune mechanism impairs β -cells, leading to insulin deficiency, whereas T 2 DM is characterized by insulin resistance and impaired glucose regulation, where the peripheral action of insulin is compromised (3).”
InfluentialTargeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes
Zeppa, S. D., Gervasi, M., Bartolacci, A., Ferrini, F., Patti, A., Sestili, P., Stocchi, V., & Agostini, D. (2024) · Nutrients · doi:10.3390/nu16223951 · Cited by 35
“Engaging in physical exercise helps to prevent obesity and acts on insulin receptors to increase muscle glucose uptake from plasma [24].”
Srisongkram, T., Waithong, S., Thitimetharoch, T., & Weerapreeyakul, N. (2022) · Nutrients · doi:10.3390/nu14020267 · Cited by 30
Shi, Y., Zhang, Y., Luo, H., Xu, F., Gao, J.-M., Shi, J., & Gong, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.828473 · Cited by 35
“With the progression of T2DM, patients suffer from hyperglycemia, dyslipidemia, and insulin resistance, as well as devastating complications, including diabetic neuropathy, diabetic retinopathy, and diabetic nephropathy (Galicia-Garcia et al., 2020).”
BackgroundSong, X., Zhu, Z., Qian, X., Liu, X., Chen, S., & Tang, H. (2022) · Molecules · doi:10.3390/molecules27061904 · Cited by 30
“Type 2 diabetes (T2DM) is a group of metabolic syndromes strongly influenced by a complex combination of metabolic, genetic, and environmental factors [1].”
BackgroundSecond Sphere Interactions in Amyloidogenic Diseases
Roy, M., Nath, A. K., Pal, I., & Dey, S. G. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00941 · Cited by 29
Li, J., Huang, P., Xiong, J., Liang, X., Li, M., Ke, H., Chen, C., Han, Y., Huang, Y., Zhou, Y., et al. (2022) · Endocrine Connections · doi:10.1530/ec-22-0012 · Cited by 33
Li, J., Shi, L., Zhao, G., Sun, F., Nie, Z., Ge, Z., Gao, B., & Yang, Y. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01873-5 · Cited by 31
“Along with cardiovascular disease and tumors, T2DM is now another chronic noncommunicable disease that poses a serious health risk to the public [2, 3].”
BackgroundPan, S., Worker, C. J., & Feng, Y. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00533.2022 · Cited by 36
Xie, Q., Zhang, X., Zhou, Q., Xu, Y., Sun, L., Wen, Q., Wang, W. J., & Chen, Q. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1179705 · Cited by 32
“Therefore, preserving and restoring functional pancreatic beta cells is a daunting challenge in treating diabetes, regardless of its type (Galicia-Garcia et al., 2020; Batista et al., 2021).”
BackgroundCurrent status of diabetes mellitus care and management in the Philippines
Cando, L. F. T., Quebral, E. P. B., Ong, E. P., Catral, C. D. M., Relador, R. J. L., Velasco, A. J. D., Alcazar, R. M. U., Reyes, N. A. L., Pilotin, E. J. B., Ornos, E. D. B., et al. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.102951 · Cited by 43
Li, Y., Lou, N., Liu, X., Zhuang, X., & Chen, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116755 · Cited by 29
Khatun, M. M., Bhuia, M. S., Chowdhury, R., Sheikh, S., Ajmee, A., Mollah, F., Hasan, M. S. A., Coutinho, H. D. M., & Islam, M. T. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111291 · Cited by 30
Health literacy and self-care among adult immigrants with type 2 diabetes: a scoping review
Tørris, C., & Nortvedt, L. (2024) · BMC Public Health · doi:10.1186/s12889-024-20749-6 · Cited by 36
“…associated with the pathogenesis of T2DM, such as organ dysfunction and premature death due to microvascular (e.g., retinopathy, neuropathy, and nephropathy) and macrovascular complications (e.g., ischemic heart disease, cerebrovascular disease, and peripheral vascular disease) [2, 3, 5].”
Javrushyan, H., Nadiryan, E., Grigoryan, A., Avtandilyan, N. V., & Maloyan, A. (2022) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2022.104763 · Cited by 30
Khan, I., Kumari, P., Kumar, R., Khatri, D. K., & Singh, S. B. (2022) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2022.2108454 · Cited by 33
“…to the defective insulin secretion by pancreatic b -cells or the inability of insulin-sensitive tissues to respond to insulin, which leads to a higher level of blood glucose resulting in metabolic and vascular complications (Tesfaye et al. 2010, Galicia-Garcia et al. 2020, Ogurtsova et al. 2022).”
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.